Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols

This publication has 35 references indexed in Scilit:

• The Structure of Arylamine N-acetyltransferase from Mycobacterium smegmatis—An Enzyme which Inactivates the Anti-tubercular Drug, Isoniazid
  Journal of Molecular Biology, 2002
• Arylamine N-acetyltransferases and Drug Response
  Pharmacogenomics, 2002
• 3D Model of Human Arylamine N-Acetyltransferase 2: Structural Basis of the Slow Acetylator Phenotype of the R64Q Variant and Analysis of the Active-Site Loop
  Biochemical and Biophysical Research Communications, 2002
• The pharmacogenetics of NAT: structural aspects
  Pharmacogenomics, 2002
• Pharmacogenetics of the arylamine N-acetyltransferases
  The Pharmacogenomics Journal, 2002
• Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop
  Biochemical Journal, 2001
• Structure of arylamine N-acetyltransferase reveals a catalytic triad
  Nature Structural & Molecular Biology, 2000
• N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
  Toxicology Letters, 2000
• Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
  Cytogenetic and Genome Research, 1997
• Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression
  DNA and Cell Biology, 1990